157 A transcriptomics-based response predictor identifies potential responders among patients with negative standard markers for response to immune checkpoint blockers

157 A transcriptomics-based response predictor identifies potential responders among patients with negative standard markers for response to immune checkpoint blockers

Bibliographic Details
Main Authors:	Eytan Ruppin, Raanan Berger, Gal Dinstag, Tuvik Beker, Efrat Elis, Doreen S Ben-Zvi, Kenneth Aldape, Ranit Aharonov
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumab
by: Razelle Kurzrock, et al.
Published: (2022-12-01)

Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomics
by: Eli Pikarsky, et al.
Published: (2025-01-01)

Toward Systems Biomarkers of Response to Immune Checkpoint Blockers
by: Óscar Lapuente-Santana, et al.
Published: (2020-06-01)

Sexual selection and the evolution of obligatory sex
by: Beker Tuvik, et al.
Published: (2007-12-01)

Biomarkers for immune checkpoint blockers
by: Kirsty Wienand, et al.
Published: (2018-06-01)

Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
by: Shelly Kalaora, et al.
Published: (2020-02-01)

Trial watch: Immune checkpoint blockers for cancer therapy
by: Claire Vanpouille-Box, et al.
Published: (2017-11-01)

A Highlight of the Mechanisms of Immune Checkpoint Blocker Resistance
by: Qian Huang, et al.
Published: (2020-12-01)

Predicting cancer prognosis and drug response from the tumor microbiome
by: Leandro C. Hermida, et al.
Published: (2022-05-01)

Microbes can help explain the evolution of host altruism
by: Ohad Lewin-Epstein, et al.
Published: (2017-01-01)

In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression
by: Sanju Sinha, et al.
Published: (2020-07-01)

Targeting the NLRP3 inflammasome abrogates cardiotoxicity of immune checkpoint blockers
by: Ping Li, et al.
Published: (2025-01-01)

Perspectives of traditional Chinese medicine to patch up immune checkpoint blockers
by: Shiu Ying Tsao
Published: (2022-10-01)

Perioperative adrenergic response and the use of beta-blockers
by: Tae-Yop Kim
Published: (2014-09-01)

Considerations for treatment duration in responders to immune checkpoint inhibitors
by: Daniel Olson, et al.
Published: (2021-03-01)

Dissociating Slow Responses From Slow Responding
by: Gayatri Salunkhe, et al.
Published: (2020-10-01)

Microglial diversity by responses and responders
by: Uwe-Karsten eHanisch, et al.
Published: (2014-04-01)

Membrane proteomics of cellular responses to β-blocker carvedilol
by: Wee, Kai Fa.
Published: (2010)

P1.57 MODULATION OF ARGINASE IN RESPONSE TO WALL SHEAR STRESS
by: R.F. da Silva, et al.
Published: (2008-09-01)

Decoupling the correlation between cytotoxic and exhausted T lymphocyte states enhances melanoma immunotherapy response prediction
by: Binbin Wang, et al.
Published: (2024-06-01)

Angiotensin receptor blocker attacks armored and cold tumors and boosts immune checkpoint blockade
by: Jie Mei, et al.
Published: (2024-09-01)

Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
by: Y. Linda Wu, et al.
Published: (2023-02-01)

Physician response in surveys: Are the responders the users?
by: Swiss Medical Weekly
Published: (2006-09-01)

The respondent factors on the digital questionnaire responses
by: Muhardis Muhardis, et al.
Published: (2019-12-01)

Proteomics and metabolomics analysis of cellular responses to β-blocker carvedilol
by: Wang, Mingxuan
Published: (2012)

287 Identification of potentially safe and selective CAR targets for head and neck cancer via a pan-cancer single cell transcriptome analysis
by: Eytan Ruppin, et al.
Published: (2023-11-01)

Analyzing gene expression from whole tissue vs. different cell types reveals the central role of neurons in predicting severity of Alzheimer's disease.
by: Shiri Stempler, et al.
Published: (2012-01-01)

Correction: Analyzing Gene Expression from Whole Tissue vs. Different Cell Types Reveals the Central Role of Neurons in Predicting Severity of Alzheimer’s Disease.
by: Shiri Stempler, et al.
Published: (2012-01-01)

Genomewide transcriptional response of Escherichia coli O157:H7 to norepinephrine
by: Vijay K. Sharma, et al.
Published: (2022-02-01)

Oxazaphosphorines combined with immune checkpoint blockers: dose-dependent tuning between immune and cytotoxic effects
by: Mélanie Desbois, et al.
Published: (2020-10-01)

1306 Negative selection of ligand-receptor interactions mediating lymphocyte infiltration confers melanoma resistance to immune checkpoint blockade therapy by turning hot tumors to cold
by: Binbin Wang, et al.
Published: (2023-11-01)

Indicators of responsiveness to immune checkpoint inhibitors
by: Bradley D. Shields, et al.
Published: (2017-04-01)

The current landscape of spatial biomarkers for prediction of response to immune checkpoint inhibition
by: Hannah L. Williams, et al.
Published: (2024-08-01)

Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanoma
by: Frank Riemer, et al.
Published: (2021-09-01)

Personalized prediction of adverse heart and kidney events using baseline and longitudinal data from SPRINT and ACCORD.
by: Gal Dinstag, et al.
Published: (2019-01-01)

Case report: Pathological differences in pulmonary arterial hypertension in long-term responders to calcium channel blockers
by: Yuichi Tamura, et al.
Published: (2023-11-01)

Different cardiovascular responses to exercise training in hypertensive women receiving β-blockers or angiotensin receptor blockers: A pilot study
by: Igor M. Mariano, et al.
Published: (2022-07-01)

The association of exaggerated hypertensive response to exercise and beta-blockers use in hypertensives
by: Kadir Uğur Mert, et al.
Published: (2020-11-01)

Predictors of Therapeutic Response to Beta-blockers in Patients with Heart Failure in Taiwan
by: Hsin Hu, et al.
Published: (2007-08-01)

Heart Failure and MEF2 Transcriptome Dynamics in Response to β-Blockers
by: S. W. Tobin, et al.
Published: (2017-06-01)